These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3454969)

  • 21. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sudden heart death in ventricular heart rhythm disorders: possibilities and limits of long-term therapy].
    Lüderitz B; Manz M; Steinbeck G
    Internist (Berl); 1984 Jul; 25(7):415-20. PubMed ID: 6147323
    [No Abstract]   [Full Text] [Related]  

  • 23. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
    Cassagneau B; Calazel J; Puel J; Massabuau P; Tournadre P; Fauvel JM; Bounhoure JP; Marin T; Narula OS
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):766-72. PubMed ID: 6433839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
    Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
    Russo AM; Beauregard LM; Waxman HL
    Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for the use of amiodarone: a personal perspective.
    Scheinman MM
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I1-5. PubMed ID: 3078153
    [No Abstract]   [Full Text] [Related]  

  • 28. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New amiodarone protocol in the treatment of refractory arrhythmias].
    Salamé E; Checrallah E; Abou Jaoudé S; Halaby J
    J Med Liban; 1992; 40(4):187-9. PubMed ID: 1339904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone in long term prophylaxis.
    Katritsis D; Camm AJ
    Drugs; 1991; 41 Suppl 2():54-66. PubMed ID: 1711969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
    McGovern B; Ruskin JN
    Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
    [No Abstract]   [Full Text] [Related]  

  • 34. Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
    Scheinman MM
    Cardiologia; 1990 Jan; 35(1 Suppl):55-60. PubMed ID: 1982245
    [No Abstract]   [Full Text] [Related]  

  • 35. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
    Kerin NZ; Blevins RD; Benaderet D; Faitel K; Jarandilla R; Garfinkel C; Klein S; Rubenfire M
    Am J Cardiol; 1986 Jan; 57(1):128-30. PubMed ID: 3942055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practical aspects of studies on amiodarone and desethylamiodarone levels in the sera of chronically treated patients].
    Popławska W; Paczkowski D; Chlewicka I; Podleśny J; Walczak F; Wójcik E
    Kardiol Pol; 1987; 30(10-11):653-60. PubMed ID: 3450945
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death].
    Kasanuki H; Inaba T; Ohnisi S; Shoda M; Matuda N; Hosoda S
    Jpn Circ J; 1994; 58 Suppl 4():1309-12. PubMed ID: 7699782
    [No Abstract]   [Full Text] [Related]  

  • 39. Case history roundtable discussion. Ventricular tachycardia.
    Scheinman MM
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I26-9. PubMed ID: 3271188
    [No Abstract]   [Full Text] [Related]  

  • 40. Ventricular fibrillation in a patient with 'silent' mitral valve prolapse.
    Strasberg B; Caspi A; Kusniec J; Lewin RF; Sclarovsky S; Agmon J
    Cardiology; 1988; 75(2):149-53. PubMed ID: 3370657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.